• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System.

作者信息

Zhang Yimin, Yu Liang, Tang LingLing, Zhu Mengfei, Jin Yanqi, Wang Zhouhan, Li Lanjuan

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

Department of Infectious Diseases, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou 310022, China.

出版信息

Engineering (Beijing). 2021 Jan;7(1):11-13. doi: 10.1016/j.eng.2020.03.006. Epub 2020 Mar 20.

DOI:10.1016/j.eng.2020.03.006
PMID:32292628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118608/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09de/7118608/6574bf2c4966/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09de/7118608/6574bf2c4966/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09de/7118608/6574bf2c4966/gr1_lrg.jpg

相似文献

1
A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System.一种有前景的针对新冠病毒肺炎细胞因子风暴的靶向治疗方法：人工肝血液净化系统
Engineering (Beijing). 2021 Jan;7(1):11-13. doi: 10.1016/j.eng.2020.03.006. Epub 2020 Mar 20.
2
The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19.人工肝血液净化系统可有效改善 COVID-19 患者的细胞因子血症。
Front Immunol. 2020 Dec 23;11:586073. doi: 10.3389/fimmu.2020.586073. eCollection 2020.
3
Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19.人工肝支持系统在治疗 COVID-19 患者细胞因子风暴中的应用价值。
Int Immunopharmacol. 2021 Jan;90:107120. doi: 10.1016/j.intimp.2020.107120. Epub 2020 Oct 31.
4
Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.COVID-19 患者经体外血液净化治疗后，细胞因子风暴得到成功控制，病情得到恢复。
Int J Infect Dis. 2020 Jul;96:618-620. doi: 10.1016/j.ijid.2020.05.065. Epub 2020 May 26.
5
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.新冠病毒肺炎患者细胞因子风暴及细胞因子靶向治疗的危害：综述
J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.
6
Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.新型冠状病毒肺炎（COVID-19）中的细胞因子风暴：专家管理考量
Indian J Crit Care Med. 2020 Jun;24(6):429-434. doi: 10.5005/jp-journals-10071-23415.
7
Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm.新冠病毒感染诱导细胞因子风暴后靶向抑制炎性细胞因子的潜在治疗方法。
Interface Focus. 2021 Dec 10;12(1):20210006. doi: 10.1098/rsfs.2021.0006. eCollection 2022 Feb 6.
8
Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients.严重和危急 COVID-19 患者的血液净化：5 例患者的病例系列。
Front Public Health. 2021 Nov 17;9:741125. doi: 10.3389/fpubh.2021.741125. eCollection 2021.
9
Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination.西雅加达一家私立医院在接种疫苗前细胞因子风暴对 COVID-19 疾病严重程度的影响。
PLoS One. 2022 Jan 25;17(1):e0262438. doi: 10.1371/journal.pone.0262438. eCollection 2022.
10
How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α.全氟碳化物如何影响 2019 冠状病毒病（COVID-19）中的细胞因子风暴和血管生成：缺氧诱导因子 1α 的作用。
Inflamm Res. 2021 Jul;70(7):749-752. doi: 10.1007/s00011-021-01469-8. Epub 2021 Jun 26.

引用本文的文献

1
Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics.用于 COVID-19 管理的血液过滤系统：细胞因子风暴治疗的新方法。
Front Immunol. 2023 Apr 21;14:1064459. doi: 10.3389/fimmu.2023.1064459. eCollection 2023.
2
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now.对抗细胞因子风暴和免疫调节缺陷：截至目前采用天然产物疗法。
Front Pharmacol. 2023 Apr 12;14:1111329. doi: 10.3389/fphar.2023.1111329. eCollection 2023.
3
Recent trends in Bi-based nanomaterials: challenges, fabrication, enhancement techniques, and environmental applications.

本文引用的文献

1
[Management of COVID-19: the Zhejiang experience].[新型冠状病毒肺炎的管理：浙江经验]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(2):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02.
2
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
3
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
铋基纳米材料的最新趋势：挑战、制备、增强技术及环境应用
Beilstein J Nanotechnol. 2022 Nov 11;13:1316-1336. doi: 10.3762/bjnano.13.109. eCollection 2022.
4
Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities.新型冠状病毒肺炎中免疫细胞的耗竭和过度激活：挑战与治疗机遇。
Clin Immunol. 2022 Dec;245:109177. doi: 10.1016/j.clim.2022.109177. Epub 2022 Nov 8.
5
VIVID: End-to-End Molecular Communication Model for COVID-19.VIVID：新冠病毒的端到端分子通信模型
IEEE Trans Mol Biol Multiscale Commun. 2021 Apr 8;7(3):142-152. doi: 10.1109/TMBMC.2021.3071767. eCollection 2021 Sep.
6
Molecular Events Involved in Influenza A Virus-Induced Cell Death.甲型流感病毒诱导细胞死亡所涉及的分子事件。
Front Microbiol. 2022 Jan 7;12:797789. doi: 10.3389/fmicb.2021.797789. eCollection 2021.
7
Neoantigen-reactive T cell: An emerging role in adoptive cellular immunotherapy.新抗原反应性T细胞：在过继性细胞免疫治疗中的新作用。
MedComm (2020). 2021 Apr 23;2(2):207-220. doi: 10.1002/mco2.41. eCollection 2021 Jun.
8
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19.关于新型冠状病毒肺炎发病机制、诊断、预防及治疗的免疫学观点
Mol Biomed. 2021;2(1):1. doi: 10.1186/s43556-020-00015-y. Epub 2021 Jan 20.
9
Hemorrhage and venous thromboembolism in critically ill patients with COVID-19.新型冠状病毒肺炎危重症患者的出血与静脉血栓栓塞
SAGE Open Med. 2021 May 31;9:20503121211020167. doi: 10.1177/20503121211020167. eCollection 2021.
10
The effectiveness of continuous renal replacement therapy in critical COVID-19 patients with cytokine release syndrome: a retrospective, multicenter, descriptive study from Wuhan, China.中国武汉一项回顾性、多中心、描述性研究：细胞因子释放综合征危重症 COVID-19 患者连续性肾脏替代治疗的效果。
Aging (Albany NY). 2021 Apr 3;13(7):9243-9252. doi: 10.18632/aging.202838.
中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
4
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.湖北省三级医院新型冠状病毒病例的临床特征。
Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.
5
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.降低2019新型冠状病毒所致死亡率：宿主导向疗法应成为一种选择。
Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5.
6
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
The Middle East Respiratory Syndrome (MERS).中东呼吸综合征（MERS）。
Infect Dis Clin North Am. 2019 Dec;33(4):891-905. doi: 10.1016/j.idc.2019.08.001.
9
Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features.严重急性呼吸系统综合征：历史、流行病学和临床特征。
Infect Dis Clin North Am. 2019 Dec;33(4):869-889. doi: 10.1016/j.idc.2019.07.001.
10
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile.人类中东呼吸综合征冠状病毒感染与促炎 Th1 和 Th17 细胞因子谱有关。
Cytokine. 2018 Apr;104:8-13. doi: 10.1016/j.cyto.2018.01.025. Epub 2018 Feb 2.